Posts of - 2013

Avesthagen Pharma signs pact with Elpen Pharmaceuticals

Avesthagen Pharma signs pact with Elpen Pharmaceuticals

AVDESP is a biosimilar for Darbepoetin alfa Aranesp, which is used for treating anaemia resulting from chronic.. View…

ByByadminNov 2, 2013
Avesthagen signs license agreement with AvestaDHATM

Avesthagen signs license agreement with AvestaDHATM

Avesthagen, an integrated systems biology platform company has announced a license agreement with AvestaDHATM for animal feed application..…

ByByadminSep 20, 2013
Avesthagen granted US patent

Avesthagen granted US patent

Avesthagen has been granted patent by the US for “breakthrough” sunflower transformation and eco-friendly.. View More

ByByadminJan 20, 2013
Biosimilars to replace 70% of chemical drugs in 2 decades

Biosimilars to replace 70% of chemical drugs in 2 decades

Biosimilars, or copycat biopharmaceutical products, are set to replace some 70% of global chemical drugs over the next…

ByByadminJan 6, 2013
Image Not Found
Avesthagen in deal with Elpen for biosimilar Aranesp in parts of Europe

Avesthagen in deal with Elpen for biosimilar Aranesp in parts of Europe

Avesthagen Pharma AG, a unit of India’s Avesthagen Ltd, has signed an agreement with Greek life sciences.. View…

ByByadminNov 21, 2013
Avesthagen Pharma signs pact with Elpen Pharmaceuticals for biosimilar AVDESPTM

Avesthagen Pharma signs pact with Elpen Pharmaceuticals for biosimilar AVDESPTM

Avesthagen Pharma has announced an agreement with Elpen Pharmaceutical Co, a leader in life-sciences for the distribution.. View…

ByByadminNov 20, 2013
error: